Recent years have witnessed remarkable progress in the management of muscular dystrophy. Scientists are actively studying innovative methods that hold hope for improving the lives of individuals stricken by this degenerative illness. Drug development have emerged as particularly promising directions for tackling the underlying mechanisms of muscula